Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …

Abstract The Apolipoprotein E ε4 (ApoE ε4) allele, encoding ApoE4, is the strongest genetic
risk factor for late-onset Alzheimer's disease (LOAD). Emerging epidemiological evidence …

Abstract Background The World Alzheimer Report showed that 46.8 million people suffered
from dementia in 2015. This study examined how the duration and quality of sleep are …

Introduction We evaluated whether insomnia symptom severity was associated with
cognitive function, and whether this relationship was modified by biomarkers associated with …

INTRODUCTION Measuring day‐to‐day sleep variability might reveal unstable sleep‐wake
cycles reflecting neurodegenerative processes. We evaluated the association between …

Inflammation in elderly is associated with physical and cognitive morbidity and mortality. We
aimed to explore the association of modifiable lifestyle parameters with inflammation among …

Background Apolipoprotein E ε4 (APOE ε4) was shown to be a risk factor for mild cognitive
impairment (MCI) and Alzheimer's disease (AD) dementia. When coupled with sleep …

Identifying modifiable factors that may predict long-term cognitive decline in the elderly with
adequate daily functionality is critical. Such factors may include poor sleep quality and …

Background: Apolipoprotein E (ApoE) is the leading genetic risk factor for late-onset
Alzheimer's disease (AD), which is the leading cause of dementia worldwide. Most people …

To examine the associations of apolipoprotein E (APOE) carrier status and lipid profiles with
sleep disorders, including excessive daytime sleepiness (EDS) and probable rapid eye …